IL22 and inflammatory bowel disease: In support of a pathogenic role of ILC3s in intestinal inflammation (Figure 3), Geremia et al. showed that IL-23 responsive ILC3s were increased in the intestines of patients with CD, where in response to IL-23 they produced high levels of IBD-relevant cytokines such as IL-17 and IL-22 (66).